2018 News Archives
First Federal Lawsuit Spawns from FDA Approval of Cannabis-Based CBD
In the wake of the June 25th decision by the Federal Drug Administration to approve a cannabis-based CBD-rich epilepsy medication from GW Pharma, a new lawsuit has been filed by a medical marijuana user against the federal government.
The plaintiff is essentially calling the FDA as her first witness and this has the federal government tiptoeing through a minefield of their own making.
